Table of Contents
1 Table of Contents 2
- 1.1 List of Tables 5
- 1.2 List of Figures 6
2 Introduction 7
- 2.1 What Is This Report About? 7
- 2.2 Definitions 7
- 2.2.1 Peripheral vascular devices 7
- 2.3 Market Overview 8
3 Key Technologies in the Peripheral Vascular Devices Market 9
- 3.1 Continuous Enhanced Circulation Therapy (C.E.C.T.) 9
- 3.2 Endexo technology 10
4 Peripheral Vascular Devices Pipeline Products Analysis 12
- 4.1 Pipeline Products by Category and Geography 12
5 Pipeline Products by Category and Development Stage 14
6 Key Peripheral Vascular Pipeline Devices 16
- 6.1 RADIMAX Self expanding Nitinol Peripheral Stent System 17
- 6.1.1 Product Description 17
- 6.1.2 Product Status 17
- 6.2 MISAGO peripheral stent 17
- 6.2.1 Product Description 17
- 6.2.2 Product Status 18
- 6.3 E-LUMINEXX iliac stent 18
- 6.3.1 Product Description 18
- 6.3.2 Product Status 18
- 6.4 Talent Abdominal Stent Graft System 19
- 6.4.1 Product Description 19
- 6.4.2 Product Status 19
- 6.5 Talent Thoracic Stent Graft System 20
- 6.5.1 Product Description 20
- 6.5.2 Product Status 20
- 6.6 Valiant Thoracic Stent Graft 21
- 6.6.1 Product Description 21
- 6.6.2 Product Status 21
- 6.7 Bypass Grafts 21
- 6.7.1 Product Description 21
- 6.7.2 Product Status 22
- 6.8 MultiGeneGraft 22
- 6.8.1 Product Description 22
- 6.8.2 Product Status 23
- 6.9 Cook' s Zenith 36mm Diameter Renu AAA Ancillary Graft 23
- 6.9.1 Product Description 23
- 6.9.2 Product Status 24
- 6.10 JOKER Peripheral Balloon Catheter 24
- 6.10.1 Product Description 24
- 6.10.2 Product Status 24
- 6.11 Option LT Vena Cava Filter 25
- 6.11.1 Product Description 25
- 6.11.2 Product Status 25
7 Global Peripheral Vascular Devices Pipeline Product Summary 26
8 Global Peripheral Vascular Devices Pipeline Trial Summary 29
9 Appendix 34
- 9.1 Research Methodology 34
- 9.2 Coverage 34
- 9.3 Secondary Research 35
- 9.4 Primary Research 36
- 9.5 Models 36
- 9.6 Forecasts 37
- 9.7 Expert Panels 37
- 9.8 6.8 GlobalData Consulting 37
- 9.9 6.9 Contact Us 37
- 9.10 6.10 Disclaimer 38
|
Related Report
|